Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harada

Showing results (1-10 of 27,885) with videos related to

Pageof 2,789
Sort By:
Nippon Ganka Gakkai Zasshi|December 9, 2004
[Function of glial cell network as a modulator of neural cell death during retinal degeneration]Takayuki Harada, Chikako Harada
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 4, 2016
[Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment]Yuka Harada, Hironori Harada
Documenta Ophthalmologica. Advances in Ophthalmology|August 15, 1985
Six cases of central serous choroidopathy induced by systemic corticosteroid therapyT Harada, K Harada
Journal of Cellular Biochemistry|January 27, 2011
Molecular mechanisms that produce secondary MDS/AML by RUNX1/AML1 point mutationsYuka Harada, Hironori Harada
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 9, 2013
[Acute promyelocytic leukemia]Yuka Harada, Hironori Harada
Journal of Cellular Physiology|April 1, 2009
Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutationsYuka Harada, Hironori Harada
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 9, 2012
[Therapy-related myeloid neoplasms]Yuka Harada, Hironori Harada
Cancer Science|January 23, 2015
Recent advances in myelodysplastic syndromes: Molecular pathogenesis and its implications for targeted therapiesHironori Harada, Yuka Harada
Critical Reviews in Eukaryotic Gene Expression|January 5, 2006
Point mutations in the AML1/RUNX1 gene associated with myelodysplastic syndromeHironori Harada, Yuka Harada
Physical Review Letters|July 9, 1990
Comment on "Quantization of self-dual field revisited"Harada
Pageof 2,789

Showing results (1-10 of 27,885) with videos related to

Sort By:
Pageof 2,789
Nippon Ganka Gakkai Zasshi|December 9, 2004
[Function of glial cell network as a modulator of neural cell death during retinal degeneration]Takayuki Harada, Chikako Harada
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 4, 2016
[Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment]Yuka Harada, Hironori Harada
Documenta Ophthalmologica. Advances in Ophthalmology|August 15, 1985
Six cases of central serous choroidopathy induced by systemic corticosteroid therapyT Harada, K Harada
Journal of Cellular Biochemistry|January 27, 2011
Molecular mechanisms that produce secondary MDS/AML by RUNX1/AML1 point mutationsYuka Harada, Hironori Harada
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 9, 2013
[Acute promyelocytic leukemia]Yuka Harada, Hironori Harada
Journal of Cellular Physiology|April 1, 2009
Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutationsYuka Harada, Hironori Harada
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 9, 2012
[Therapy-related myeloid neoplasms]Yuka Harada, Hironori Harada
Cancer Science|January 23, 2015
Recent advances in myelodysplastic syndromes: Molecular pathogenesis and its implications for targeted therapiesHironori Harada, Yuka Harada
Critical Reviews in Eukaryotic Gene Expression|January 5, 2006
Point mutations in the AML1/RUNX1 gene associated with myelodysplastic syndromeHironori Harada, Yuka Harada
Physical Review Letters|July 9, 1990
Comment on "Quantization of self-dual field revisited"Harada
Pageof 2,789